|
|
Volumn 49, Issue 12, 2013, Pages 799-801
|
|
Business of Biosimilars - 14th Annual Conference (October 15-17, 2013 - Boston, Massachusetts, USA)
a
|
|
Author keywords
Biologics; Biosimilar regulations; Biosimilars
|
|
Indexed keywords
BIOSIMILAR AGENT;
GENERIC DRUG;
COMPETITION;
CONFERENCE PAPER;
COST CONTROL;
DRUG INDUSTRY;
DRUG MANUFACTURE;
HEALTH CARE INDUSTRY;
HEALTH CARE ORGANIZATION;
HUMAN;
PHYSICIAN;
UNITED STATES;
BIOLOGICS;
BIOSIMILAR REGULATIONS;
DRUG DESIGN;
DRUG LEGISLATION;
ECONOMIC ASPECT;
ECONOMICS;
ORGANIZATION AND MANAGEMENT;
BIOLOGICS;
BIOSIMILAR REGULATIONS;
BIOSIMILARS;
BIOSIMILAR PHARMACEUTICALS;
DRUG DESIGN;
DRUG INDUSTRY;
DRUGS, GENERIC;
ECONOMIC COMPETITION;
HUMANS;
LEGISLATION, DRUG;
|
|
EID: 84892732680
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: 10.1358/dot.2013.49.12.2097802 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
